Topics

Clough Harbour & Associates LLP Company Profile

22:59 EDT 28th March 2020 | BioPortfolio

Driving a highway should be like a visit to the symphony,” CHA-founder and highway engineer John Clarkson said famously. He saw how the blacktop’s path could set a cadence, how reaching a hilltop could be a crescendo. John had a passion for engineering like none other.
While the diversity of our services has grown tremendously over the decades, one thing has remained constant. John’s vision - that, if well-designed, even the everyday can be extraordinary – still defines our every project.

Location

III Winners CircleP.O. Box 5269
Albany
New York
12205-0269
United States of America

Contact

Phone: (518) 453-4500
Fax: (518) 458-1735
Email: info@cloughharbour.com


News Articles [166 Associated News Articles listed on BioPortfolio]

Harbour BioMed Completes China Phase II Trial of Dry Eye Treatment

Harbour BioMed (HBM) completed a China Phase II trial of HBM9036 (tanfanercept), a novel TNF receptor-1 fragment indicated for moderate-to-severe Dry-Eye-Disease. In 2017, Harbour in-licensed China ri...

Harbour BioMed to Begin US Trials of CLTA-4 Antibody

Harbour BioMed (HBM), a China-US-Dutch biopharma, was approved to start US clinical trials of its next-gen CLTA-4 antibody in patients with solid tumors. The company discovered HBM4003, a fully human ...

Harbour BioMed Tacks on $75M to Advance Broad Biologics Pipeline

A biotech born out of an antibody platform company has added another $75 million to its investment haul, money it says will allow it to advance its clinical-stage compounds and continue to build its p...

Harbour BioMed and NYC's Mount Sinai Form mAb Discovery Partnership

Harbour BioMed partnered with Mount Sinai Health System of New York City to discover novel antibodies that treat/prevent oncology and immunology diseases, starting with a COVID-19 mAb. HBM will use it...

Harbour BioMed Approved to Start US Trials of PD-L1 in Orphan Disease

Harbour BioMed announced US approval of an IND to conduct a Phase II trial of its PD-L1 candidate in patients with nasopharyngeal cancer (NPC). The US FDA also granted Orphan Drug Designation to HBM91...

Harbour BioMed Raises $75 Million to Advance Cancer/Immunological Portfolio

Harbour BioMed (HBM) raised $75 million in a Series B+ round to advance its clinical-stage compounds and portfolio of next-gen biotherapies for cancer and immunological diseases. The company builds it...

PPD signed on as preferred provider for Harbour BioMed

Harbour BioMed has selected PPD as its preferred CRO partner as part of a strategic collaboration to develop novel oncology and immunology therapeutics.

Mount Sinai and Harbour BioMed collaborate to advance novel biotherapies to treat cancer and coronavirus COVID-19

The collaboration will also utilize the H2L2 Harbour Mice® platform to generate monoclonal antibodies against the coronavirus SARS CoV 2 – COVID-19 (commonly known as COVID-19). These fully The po...

Drugs and Medications [39 Associated Drugs and Medications listed on BioPortfolio]

Quflora pediatric [carwin pharmaceutical associates, llc]

Quflora™ Pediatric Chewable Tablets

Quflora pediatric drops [carwin pharmaceutical associates, llc]

Quflora 0.25 mg/mL F* Pediatric Fluoride Drops

Quflora pediatric drops [carwin pharmaceutical associates, llc]

Quatrefolic 0.5 mg/mL F* Pediatric Fluoride Drops

Quflora fe pediatric drops [carwin pharmaceutical associates, llc]

Quflora FE Pediatric Liquid Drops

Ibuprofen [pharmaceutical associates, inc.]

Ibuprofen Oral Suspension USP 100 mg/5 mL

PubMed Articles [139 Associated PubMed Articles listed on BioPortfolio]

Stoichiometry and regulation network of Bcl-2 family complexes quantified by live-cell FRET assay.

The stoichiometry and affinity of Bcl-2 family complexes are essential information for understanding how their interactome network is orchestrated to regulate mitochondrial permeabilization and apopto...

Symptom severity in burning mouth syndrome associates with psychological factors.

Burning mouth syndrome (BMS) patients are psychologically distressed, but whether this associates with symptom severity is unclear.

The dynamics of dissolved inorganic nitrogen species mediated by fresh submarine groundwater discharge and their impact on phytoplankton community structure.

Submarine groundwater discharge (SGD)-driven nutrient inputs have long been speculated to sustain the high frequency of red tide occurrence in Tolo Harbour, Hong Kong, for its larger flux and higher n...

Forensic microbiology reveals that Neisseria animaloris infections in harbour porpoises follow traumatic injuries by grey seals.

Neisseria animaloris is considered to be a commensal of the canine and feline oral cavities. It is able to cause systemic infections in animals as well as humans, usually after a biting trauma has occ...

Characterization of a Novel Rhabdovirus Isolated from a Stranded Harbour Porpoise (Phocoena phocoena).

An adult male harbour porpoise (Phocoena phocoena) stranded off the coast of Alaska displaying poor body condition, scattered mild ulcerative dermatitis, and necrotizing balanoposthitis. Necropsy find...

Clinical Trials [99 Associated Clinical Trials listed on BioPortfolio]

Frailty and Mortality in Older Old With Severe Aortic Stenosis

BACKGROUND.- The frailty syndrome (FS) associates an increase in morbidity and mortality in the elderly patient. When severe and symptomatic, aortic stenosis (AS) is a disease with poor pr...

GORE VIABAHN® Versus Plain Old Balloon Angioplasty (POBA) for Superficial Femoral Artery (SFA) In-Stent Restenosis

This is a prospective, randomized, multi-center study recruiting patients with an in-stent restenosis in the superficial femoral artery. The safety and efficacity of the Viabahn endoprosth...

ESBL in Patients Returning to Sweden With Traveller's Diarrhoea

Patients with traveller's diarrhoea frequently harbour Extended Spectrum Betalactamase (ESBL)-producing Enterobacteriaceae (EPE) returning from EPE-endemic areas. This study investigates ...

Endoscopic Resection of Gastric Subepithelial Masses, EndoResect Study

Gastric subepithelial masses might harbour gastrointestinal stromal tumors, which should get resected because of their malignant potential. To minimize the associated surgical trauma endos...

Mobility Rehab, a Therapist-assisted System for Gait Rehabilitation

Phase II of this study includes a pragmatic clinical trial which will take place at Northwest Rehabilitation Associates (NWRA) in Salem, OR to verify the efficacy of the system in a physic...

Companies [793 Associated Companies listed on BioPortfolio]

Clough Harbour & Associates LLP

Driving a highway should be like a visit to the symphony,” CHA-founder and highway engineer John Clarkson said famously. He saw how the blacktop’s path could set a cadence, how reaching a hilltop ...

Harbour BioMed

Harbour BioMed is a global biopharmaceutical company discovering and developing innovative therapeutics for cancer, with a focus on immuno-oncology, and immunological diseases. Th...

Harbour Point Capital

Harbour Point Capital (“HPC”) is an independent private equity firm specializing in healthcare investing. The co-founders of HPC have worked together for eight years ...

Harbour Antibodies BV

Harbour Antibodies BV was established in 2006 to use transgenic mouse technology developed in the laboratory of Professor Frank Grosveld at Erasmus MC (Rotterdam, the Netherlands)...

TA Associates TA Associates

Founded in 1968, TA Associates is one of the largest and most experienced middle market private equity firms. The firm has invested in over 400 companies and manages more than US ...

More Information about "Clough Harbour & Associates LLP" on BioPortfolio

We have published hundreds of Clough Harbour & Associates LLP news stories on BioPortfolio along with dozens of Clough Harbour & Associates LLP Clinical Trials and PubMed Articles about Clough Harbour & Associates LLP for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Clough Harbour & Associates LLP Companies in our database. You can also find out about relevant Clough Harbour & Associates LLP Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks



Searches Linking to this Company Record